Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of HBI-3000 in healthy volunteers
NCT03397641Phase 1Completed
- Sponsor
- HUYABIO International, LLC
- Start
- Oct 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sulcardine in Atrial fibrillation (AFib) (2 arms), sponsored by HUYABIO International, LLC. Primary endpoints: Physical Examination, Safety Laboratory Tests and 7 more. Started Oct 2017; status: completed.
02
Drugs
sulcardine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03397641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03397641.